Filing Details

Accession Number:
0001209191-21-004750
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-21 19:12:38
Reporting Period:
2021-01-20
Accepted Time:
2021-01-21 19:12:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649094 Vaxcyte Inc. PCVX Biological Products, (No Disgnostic Substances) (2836) 464233385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1813798 Jim Wassil C/O Vaxcyte, Inc.
353 Hatch Drive
Foster City CA 94404
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-20 3,000 $2.42 19,381 No 4 M Direct
Common Stock Disposition 2021-01-20 3,000 $25.50 16,381 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-01-20 3,000 $0.00 3,000 $2.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
248,926 2029-12-16 No 4 M Direct
Footnotes
  1. Includes 1,562 shares acquired under the Employment Stock Purchase Plan on November 17, 2020.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. The price reported is a weighted-average price. The shares were sold at prices ranging from $25.50 to $25.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.